Strategic Acquisition CoaguSense recently expanded its capabilities by acquiring DOAC testing assets from DOASENSE GmbH, signaling a potential upsell path to customers seeking broader anticoagulation monitoring solutions and cross-sell opportunities with related diagnostic assets.

Acquired Parent As a subsidiary of i-SENS, Inc., CoaguSense benefits from an established distribution and technology footprint in point-of-care diagnostics, suggesting opportunities to collaborate with i-SENS’s existing customer base and leverage shared channels for faster penetration.

Point-of-Care Advantage The Coag-Sense system offers direct clot detection with high accuracy for PT/INR monitoring, a compelling value proposition for clinics, ambulatory surgery centers, and home care providers seeking reliable, rapid coagulation results that can reduce monitoring downtime and improve patient outcomes.

Growth Signals Operating with a lean team and modest revenue, CoaguSense presents a scalable target for integration partnerships, value-based pricing pilots, and tiered service offerings that align with mid-market and regional hospital networks looking to expand anticoagulation monitoring capabilities.

Digital & Channel Stronghold Active digital presence and tech stack elements (Google Ads, Shopify, Pardot, WordPress) indicate readiness for digital demand generation, remarketing, and channel partnerships to accelerate lead generation, especially in medical distributors and care facilities seeking turnkey PT/INR solutions.